Jennison Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.25B | Buy |
|
|||||
|
2025
Q1 | $4.31B | Buy |
|
|||||
|
2024
Q4 | $3.7B | Sell |
|
|||||
|
2024
Q3 | $6.15B | Sell |
|
|||||
|
2024
Q2 | $6.55B | Sell |
|
|||||
|
2024
Q1 | $5.81B | Sell |
|
|||||
|
2023
Q4 | $4.43B | Sell |
|
|||||
|
2023
Q3 | $4.52B | Sell |
|
|||||
|
2023
Q2 | $4.02B | Buy |
|
|||||
|
2023
Q1 | $2.94B | Sell |
|
|||||
|
2022
Q4 | $3.82B | Buy |
|
|||||
|
2022
Q3 | $3.25B | Sell |
|
|||||
|
2022
Q2 | $3.36B | Buy |
|
|||||
|
2022
Q1 | $2.26B | Sell |
|
|||||
|
2021
Q4 | $2.53B | Sell |
|
|||||
|
2021
Q3 | $2.28B | Buy |
|
|||||
|
2021
Q2 | $2.05B | Buy |
|
|||||
|
2021
Q1 | $1.02B | Buy |
|
|||||
|
2020
Q4 | $317M | Sell |
|
|||||
|
2020
Q3 | $678M | Sell |
|
|||||
|
2020
Q2 | $1.32B | Sell |
|
|||||
|
2020
Q1 | $1.41B | Buy |
|
|||||
|
2019
Q4 | $593M | Buy |
|
|||||
|
2019
Q3 | $152M | Sell |
|
|||||
|
2019
Q2 | $174M | Sell |
|
|||||
|
2019
Q1 | $474M | Buy |
|
|||||
|
2018
Q4 | $396M | Buy |
|
|||||
|
2018
Q3 | $230M | Buy |
|
|||||
|
2018
Q2 | $162M | Buy |
|
|||||
|
2018
Q1 | $147M | Sell |
|
|||||
|
2017
Q4 | $192M | Buy |
|
|||||
|
2017
Q3 | $172M | Buy |
|
|||||
|
2017
Q2 | $160M | Buy |
|
|||||
|
2017
Q1 | $144M | Sell |
|
|||||
|
2016
Q4 | $128M | Buy |
|
|||||
|
2016
Q3 | $104M | Sell |
|
|||||
|
2016
Q2 | $103M | Buy |
|
|||||
|
2016
Q1 | $39.6M | Sell |
|
|||||
|
2015
Q4 | $46.4M | Sell |
|
|||||
|
2015
Q3 | $89.3M | Buy |
|
|||||
|
2015
Q2 | $87.9M | Buy |
|
|||||
|
2015
Q1 | $75.9M | Sell |
|
|||||
|
2014
Q4 | $72.5M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $3.81M | Buy |
|
|||||
|
2014
Q1 | $2.94M | Sell |
|
|||||
|
2013
Q4 | $3.49M | Buy |
|
|||||
|
2013
Q3 | $3.13M | Buy |
|